Pervasiveness of HLA allele-specific expression loss across tumor types
ConclusionsTogether, our results highlight the prevalence of HLA-I ASE loss and provide initial evidence of its clinical significance in cancer prognosis and immunotherapy treatment.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Genetics | Immunotherapy | Melanoma | Pancreas | Pancreatic Cancer | Skin Cancer